Figure 3: Biomanufacuting capacity in North America, 2002 projected to 2015. Mammalian-based GMP clinical and commercial facilities. Disposable and roller bottles systems were excluded from analysis due to the difficulty assessing and forecasting their volume accurately. Adapted from Levine 2010 and Reynolds 2010 [5,7].